MAXIMUS, Inc. (MMS) Holdings Lifted by American International Group Inc.

American International Group Inc. raised its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 176,692 shares of the health services provider’s stock after buying an additional 907 shares during the period. American International Group Inc. owned about 0.27% of MAXIMUS worth $12,648,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in MMS. Mondrian Investment Partners LTD purchased a new stake in shares of MAXIMUS in the fourth quarter valued at approximately $51,945,000. Victory Capital Management Inc. boosted its holdings in shares of MAXIMUS by 13.3% in the third quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock valued at $226,667,000 after purchasing an additional 413,325 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of MAXIMUS by 1,629.4% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 389,120 shares of the health services provider’s stock valued at $27,853,000 after purchasing an additional 366,620 shares during the period. APG Asset Management N.V. boosted its holdings in shares of MAXIMUS by 316.2% in the fourth quarter. APG Asset Management N.V. now owns 380,800 shares of the health services provider’s stock valued at $22,700,000 after purchasing an additional 289,300 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its holdings in shares of MAXIMUS by 39.2% in the third quarter. Schwab Charles Investment Management Inc. now owns 689,814 shares of the health services provider’s stock valued at $44,494,000 after purchasing an additional 194,225 shares during the period. Institutional investors and hedge funds own 96.76% of the company’s stock.

Shares of MAXIMUS, Inc. (NYSE MMS) opened at $68.16 on Friday. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $4,444.97, a price-to-earnings ratio of 21.43, a price-to-earnings-growth ratio of 2.27 and a beta of 1.21. MAXIMUS, Inc. has a twelve month low of $57.12 and a twelve month high of $72.71.

MAXIMUS (NYSE:MMS) last posted its earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.01. The company had revenue of $623.10 million during the quarter, compared to analyst estimates of $624.36 million. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%. MAXIMUS’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.71 earnings per share. equities analysts forecast that MAXIMUS, Inc. will post 3.44 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.045 per share. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 dividend on an annualized basis and a yield of 0.26%. MAXIMUS’s dividend payout ratio is currently 5.36%.

A number of analysts recently issued reports on the company. Maxim Group reiterated a “hold” rating and issued a $69.00 price target (up previously from $66.00) on shares of MAXIMUS in a report on Thursday, February 8th. Canaccord Genuity reiterated a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. Finally, Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price target for the company in a report on Tuesday, February 13th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $66.60.

In other MAXIMUS news, CEO Richard A. Montoni sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $67.42, for a total transaction of $674,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mark Andrekovich sold 5,000 shares of the company’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $68.80, for a total value of $344,000.00. Following the sale, the insider now owns 22,996 shares of the company’s stock, valued at approximately $1,582,124.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 102,650 shares of company stock valued at $7,034,142. 3.10% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece was published by Week Herald and is the sole property of of Week Herald. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://weekherald.com/2018/02/24/maximus-inc-mms-holdings-lifted-by-american-international-group-inc.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply